Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

December 01, 1996; 47 (6) Clinical Scientific Notes

Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome

U. Nagaoka, T. Kato, K. Kurita, S. Arawaka, T. Hosoya, N. Yuki, Y. Shikama, K. Yamaguchi, H. Sasaki
First published December 1, 1996, DOI: https://doi.org/10.1212/WNL.47.6.1601
U. Nagaoka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Kato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Kurita
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Arawaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Hosoya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Yuki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Shikama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Yamaguchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Sasaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome
U. Nagaoka, T. Kato, K. Kurita, S. Arawaka, T. Hosoya, N. Yuki, Y. Shikama, K. Yamaguchi, H. Sasaki
Neurology Dec 1996, 47 (6) 1601-1602; DOI: 10.1212/WNL.47.6.1601

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
95

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Miller Fisher syndrome (MFS) is characterized by an acute onset of external ophthalmoplegia, cerebellar ataxia, and areflexia. Because MFS is often preceded by an episode of acute inflammatory symptoms and, in most cases, the neurologic symptoms recover after a certain period of time, the disease is regarded as a variant of Guillain-Barre syndrome (GBS). [1] Although the involvement of peripheral nerves is evident in GBS, controversy still exists as to the localization of lesions in MFS. [2] Here we report two cases of MFS in which, using contrast-enhanced three-dimensional (3-D) MRI, the abducens and oculomotor nerves were enhanced by Gd-DTPA.

Patient 1.

The patient was a 26-year-old man with a history of transient diarrhea and sore throat 1 week before he complained of diplopia and unstable gait. On admission (the fifth day of illness), his external ocular movements were limited to all directions with the right abducens nerve being most severely affected. His gait was ataxic and his deep tendon reflexes were completely absent. ELISA [3] showed a high titer of IgG anti-GQ1b antibody (1:3,200) in the serum. CSF examination disclosed a mild elevation of protein concentration (65 mg/dL) without pleocytosis. He was treated with double filtration plasmapheresis and immunoabsorption after the ninth day of illness. His neurologic symptoms including diplopia and ataxia were gradually ameliorated from the 13th day and his deep tendon reflexes appeared around the 24th day.

On the 10th day when his ophthalmoplegia was most severe, contrast-enhanced 3-D MRI of the brain was performed, which was obtained by spoiled gradient-recalled acquisition in a steady state, using a 1.5-T system after injection of Gd-DTPA, [4] and it revealed a marked Gd-enhancement of the right abducens nerve (Figure 1, A and B) and a slight thickening of the right oculomotor nerve. Routine brain MRI did not show any abnormality on T1- and T2-weighted images. On the 101st day when his symptoms almost disappeared, the intensity of the enhancing nerves was markedly decreased (Figure 1, C).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Contrast-enhanced 3-D MRI in Miller Fisher syndrome (A-C, patient 1; D, patient 2). Transverse (A and C) and sagittal (B and D) reformatted images through the right abducens nerve (A-C) and through the right oculomotor nerve (D) after gadolinium administration. A and B show a Gd-enhancement of the right abducens nerve (arrows), and D shows the enhancing right oculomotor nerve (arrow). The intensity of the right abducens nerve (A) is markedly decreased after symptomatic improvement (C).

Patient 2.

A 54-year-old man with a preceding history of cough and fever for 2 weeks showed progressive neurologic deficits, including diplopia, unstable gait, difficulty in writing, and then a decrease in visual acuity of both eyes. On admission the eighth day after onset), he had complete ophthalmoplegia, ataxia, and areflexia. His pupils were dilated and reactive sluggishly to light. CSF had an elevated protein concentration (72 mg/dL) without pleocytosis. With steroid treatment after the 11th day, his neurologic symptoms were ameliorated. By the 64th day, his cerebellar ataxia disappeared completely with only mild abducens palsy remaining.

On the ninth day, contrast-enhanced 3-D MRI of the brain was performed and it revealed a Gd-enhancement of the extramedullary portions of the oculomotor (Figure 1, D) and abducens nerves. No abnormality was detectable on conventional brain MRI.

Discussion.

The present two patients with MFS presented with an acute onset of external ophthalmoplegia, cerebellar ataxia, and areflexia preceded by an episode of acute inflammatory symptoms, and these neurologic signs improved or recovered. CSF examination showed a mild increase in protein concentration without pleocytosis. Although not examined in patient 2, patient 1 had anti-GQ1b antibody in the serum. In these cases, routine brain MRI did not show any abnormal findings, but contrastenhanced 3-D MRI revealed Gd-enhancement of the abducens nerves in patients 1 and 2 and of the oculomotor nerve in patient 2. Although not all affected nerves enhanced, these enhancing cranial nerves were functionally impaired most severely among the ocular nerves at the time of MRI examination. Because cranial nerves do not contrast-enhance in normal subjects, [5] the MRI findings represent involvement of the extramedullary portion of the oculomotor and abducens nerves in our cases of MFS.

Campylobacter jejuni isolated from MFS patients has a GQ1b epitope, and anti-GQ1b antibody may be found in the serum of MFS patients. [3,6,7] GQ1b is localized to the paranodal regions of the extramedullary portion of the oculomotor, trochlear, and abducens nerves. [7] Therefore, the anti-GQ1b antibody may attack the paranodes of these nerves, resulting in the induction of immunologic-inflammatory process. The present MRI findings may reflect it in the extramedullary portion of the abducens and oculomotor nerves.

In conclusion, the present observation provides direct evidence in living patients that the ophthalmoplegia in MFS results from peripheral lesions of the cranial nerves associated with ocular movements.

  • Copyright 1996 by Advanstar Communications Inc.

REFERENCES

  1. 1.↵
    Pleasure DE, Schotland DL. Acquired neuropathies. In: Rowland LP, ed. Merritt's textbook of neurology. 8th ed. Philadelphia: Lea & Febiger, 1989:609-622.
  2. 2.↵
    Al-Din AN, Anderson M, Eeg-Olofsson O, Trontelj TV. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand 1994;89:157-163.
    OpenUrlPubMed
  3. 3.↵
    Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791-793.
    OpenUrl
  4. 4.↵
    Hosoya T, Watanabe N, Yamaguchi K. Cranial nerve enhancement on three-dimensional MRI in patients with ophthalmoplegia. In: Takahashi M, Korogi Y, Moseley I, eds. Proceedings of the XV symposium neuroradiologicum. Berlin: Springer-Verlag, 1995:365-366.
  5. 5.↵
    Mark AS, Blake P, Atlas SW, Ross M, Brown D, Kolsky M. Gd-DTPA enhancement of the cisternal portion of the oculomotor nerve on MR imaging. AJNR 1992;13:1463-1470.
    OpenUrlPubMed
  6. 6.
    Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-679.
    OpenUrl
  7. 7.↵
    Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
    OpenUrlAbstract/FREE Full Text
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Patient 1.
    • Patient 2.
    • Discussion.
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise